Integrity Coronary Stent System    

Log In
 
 

Forgot Your Password?
 


Not a member? Click here!

Cordis Corporation Launches Family of REGATTA(TM) Steerable Guidewires
The COURAGE Trial
Contrast Nephropathy recommendations
Multi Bene Study
ZoMaxx IVUS






 

 

Simplicity Remains the Rule in Bifurcation Stenting

Provisional main branch (MB) stenting is the current recommended strategy in bifurcation lesions. The TRYTON study is the latest study to compare a strategy of bifurcation stenting using a dedicated bifurcation stent with provisional stenting of the MB. TRYTON has shown similar target vessel failure rates and binary restenosis rates at 9 months follow-up.

For more, click here

 

 

 

Ischemic Lesions Post CAS Not Innocent Bystanders

The clinical significance of ischemic brain lesions following carotid artery stenting (CAS) is unknown. The MRI sub-study of the International Carotid Stenting Study has indicated that ischemic brain lesions post CAS is a marker of recurrent cardiovascular events over a 4.1 years follow-up.

For more, click here

 

 

 

Autonomic Dysfunction Post Thoracic Irradiation

The clinical impact of thoracic irradiation (TI) upon exercise capacity and CV mortality in Hodgkin Lymphoma (HL) survivors is unknown. A study of 263 HL survivors has indicated that TI is associated with elevated resting heart rate and abnormal heart rate recovery both of which were associated with reduced exercise capacity. Abnormal heart rate recovery was found to be associated with increased all-cause mortality.

For more, click here

 

 

 

Importance of BP Lowering Across the CV Spectrum in Type II DM

BP control has been one of the fundamental aspects of diabetes management. A meta-analysis of 40 trials has indicated that each 10-mmHg lower systolic BP may be associated with lower risk of mortality, CV events, coronary heart disease, stroke, albuminuria, and retinopathy.

For more, click here

 

<
||
>













CRT2013
Untitled Document
 
CoreValve US Pivotal Trial
- John V. Conte, MD
Myocardial infarction with no obstructive coronary atherosclerosis
- Giampaolo Niccoli, MD, PhD
Incidence, Predictors, and Prognostic Impact of Late Bleeding (≥30 days) Complications after Transcatheter Aortic Valve Replacement (TAVR)
- Philippe Généreux, MD
Minimizing Femoral Artery Access Complications during PCI
- Michael S. Lee, MD



Live Case Demonstration from Kusatsu Heart Center
Osamu Hatoh, MD
Treating CTO via Radial?
Richard R. Heuser, MD
Patient Selection for CTO Recanalization: What Are the Appropriate Criteria?
Tarek Helmy, MD
Treating CTOs: Is There Enough Evidence-Based Data or do We Need Further Randomized Clinical Trials?
Gerald S. Werner, MD, PhD
Indication for CTO PCI: Clinical Rationale and Appropriateness
J. Aaron Grantham, MD
 Click here to visit the WEBEX archives


A Randomized Trial of a Dedicated Bifurcation Stent Versus Provisional Stenting in the Treatment of Coronary Bifurcation Lesions.
Philippe Généreux, et al.
JACC 2015, 65:533-543
Ischemic Brain Lesions After Carotid Artery Stenting Increase Future Cerebrovascular Risk.
Henrik Gensicke, et al.
JACC 2015; 65:521-529
ApoB-100–Related Peptide Vaccine Protects Against Angiotensin II–Induced Aortic Aneurysm Formation and Rupture.
Tomoyuki Honjo, et al.
JACC 2015; 65:546-556
Interaction of Impaired Coronary Flow Reserve and Cardiomyocyte Injury on Adverse Cardiovascular Outcomes in Patients Without Overt Coronary Artery Disease.
V Taqueti, et al.
Circ 2015; 131:528-535
Integromic Analysis of Genetic Variation and Gene Expression Identifies Networks for Cardiovascular Disease Phenotypes.
C Yao, et al.
Circ 2015; 131:536-549
Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction.
S Mohammed, et al.
Circ 2015; 131:550-559
Endocarditis Pathogen Promotes Vegetation Formation by Inducing Intravascular Neutrophil Extracellular Traps Through Activated Platelets.
C Jung, et al.
Circ 2015; 131:571-581
Blood Pressure Lowering in Type 2 Diabetes: A Systematic Review and Meta-analysis.
C Emdin, et al.
JAMA 2015; 313:603-615
Trends and Predictors of Smoking Cessation After Percutaneous Coronary Intervention (from Olmsted County, Minnesota, 1999 to 2010).
O Sochor, et al.
AJC 2015; 115:405-410
Impact of Female Sex on Lipid Lowering, Clinical Outcomes, and Adverse Effects in Atorvastatin Trials.
P Hsue, et al.
AJC 2015; 115:447-453
Translation of Acute Coronary Syndrome Therapies: From Evidence to Routine Clinical Practice.
M Putera, et al.
AHJ 2015; 169:266-273



Poll Archives
CRT 2015 Monday / Tuesday
CRT 2015 Sunday / Monday
CRT 2015 Weekend In Review

Complex Patients Today and Tomorrow: Medtronic DES solutions from Resolute Integrity to bioresorbable stents
Prof. Sigmund Silber, MD
First Report on the Pivotal DESolve Nx trial: 6-month Clinical and Multimodality Imaging Results
Alexandre Abizaid, MD, PhD
One-Year Outcomes in 1010 Unselected Patients Treated with the PROMUS Element Everolimus-Eluting Stent: The Multicenter PROMUS Element European Post-Approval Surveillance Study
Raul Moreno, MD, et al.
Two-year clinical outcomes in the EVOLVE FHU trial
Ian Meredith, MD, PhD
BIOFLOW-II Trial
Stephan Windecker, MD, et al.

Outcomes in More Than 7000 Patients With Diabetes After Implantation of the Resolute Zotarolimus-eluting Stent
Rosli Mohd Ali, MD
Safety update and long-term clinical outcomes from all studies in the RESOLUTE Global Clinical Program
Carlo Di Mario, MD
Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial
Stephan Windecker, MD
Angina Status & TLF Creep: Bioabsorbable Stents (BAS) & Drug-Eluting Stents (DES)
Medtronic, Inc.
Clinical outcomes associated with dual antiplatelet therapy interruption following implantation of the ResoluteTM zotarolimus-eluting stent
Stephan Windecker, MD
Four-year Outcomes from the Randomized Comparison of a Zotarolimus-eluting and an Everolimus-eluting Stent in the RESOLUTE All Comers Trial
Patrick W Serruys MD, PhD
Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program
Prof. Ran Kornowski, MD


ACS & AMI
Angiomyogenesis & Cell Therapy
Carotid Interventions

Home | CRT2015 | CardioTube | Interesting Cases | Trials | Weekly Poll Archive | Newsletter Archive | Login


Copyright © 2015, CRTONLINE - About / Contact Us. All rights reserved. Privacy Policy
Powered by Multiweb